当前位置:首页 - 行情中心 - 心脉医疗(688016) - 财务分析

心脉医疗

(688016)

  

流通市值:124.27亿  总市值:124.27亿
流通股本:1.23亿   总股本:1.23亿

心脉医疗(688016)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年年度实现净利润5.55亿元,每股收益4.65元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年年度最新股东权益409852.04万元,未分配利润144865.65万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年年度最新总资产464115.21万元,负债54263.16万元。

利润表
报告期2025-12-312025-09-302025-06-302025-03-31
营业总收入1,350,632,689.261,014,780,041.62714,429,779.98332,189,385.86
营业总成本756,503,750.61563,934,629.28389,156,547.64183,356,645.13
其他经营收益
营业利润654,004,276.02497,462,954.23367,106,286.54150,871,288.69
利润总额653,487,183.55497,543,031.94366,935,691.12150,865,583.5
净利润554,659,959.66423,065,173.14310,624,892.41127,995,708.88
每股收益
其他综合收益26,839,274.0138,052,254.4238,073,084.01-3,262,364.66
综合收益总额581,499,233.67461,117,427.56348,697,976.42124,733,344.22
资产负债表
报告期2025-12-312025-09-302025-06-302025-03-31
流动资产:
流动资产合计2,802,050,027.442,923,688,036.722,913,091,501.622,881,101,780.71
非流动资产:
非流动资产合计1,839,102,053.131,808,674,620.171,691,173,425.721,583,775,042.7
资产总计4,641,152,080.574,732,362,656.894,604,264,927.344,464,876,823.41
流动负债:
流动负债合计409,246,847.73615,017,835.3414,372,574.33458,518,305.05
非流动负债:
非流动负债合计133,384,801.31135,054,880.9132,345,389.86121,802,705.91
负债合计542,631,649.04750,072,716.2546,717,964.19580,321,010.96
所有者权益(或股东权益):
归属于母公司股东权益合计4,075,341,117.893,956,811,416.724,030,319,620.373,845,735,715.92
股东权益合计4,098,520,431.533,982,289,940.694,057,546,963.153,884,555,812.45
负债和股东权益合计4,641,152,080.574,732,362,656.894,604,264,927.344,464,876,823.41
现金流量表
报告期2025-12-312025-09-302025-06-302025-03-31
经营活动产生的现金流量:
经营活动现金流入小计1,454,937,070.99961,796,695.2689,206,831.71190,732,776.15
经营活动现金流出小计881,873,115.74598,595,046.84370,603,510.51150,704,991.85
经营活动产生的现金流量净额573,063,955.25363,201,648.36318,603,321.240,027,784.3
投资活动产生的现金流量:
投资活动现金流入小计4,945,976,849.832,934,168,253.082,141,974,089.84460,488,888.89
投资活动现金流出小计5,333,033,026.274,305,020,875.922,653,993,857.061,620,401,265.38
投资活动产生的现金流量净额-387,056,176.44-1,370,852,622.84-512,019,767.22-1,159,912,376.49
筹资活动产生的现金流量:
筹资活动现金流入小计126,000,000126,000,000126,000,000126,000,000
筹资活动现金流出小计475,918,588.82306,313,468.24269,362,51775,568,229.15
筹资活动产生的现金流量净额-349,918,588.82-180,313,468.24-143,362,51750,431,770.85
汇率变动对现金及现金等价物的影响-2,871,180.32255,712.02890,545.98-10,900,800.36
现金及现金等价物净增加额-166,781,990.33-1,187,708,730.7-335,888,417.04-1,080,353,621.7
期末现金及现金等价物余额1,892,049,254.81871,122,514.441,722,942,828.1978,477,623.44
补充资料:
现金及现金等价物的净增加额-166,781,990.33--335,888,417.04-
最新报告期:2026-04-06
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
申万宏源陈烨远5.205.746.602026-04-06
中金公司俞波,张琎5.045.77--2026-04-04
中泰证券祝嘉琦,谢木青5.246.177.322026-03-31
国金证券何冠洲,甘坛焕5.556.838.212026-03-30
国金证券何冠洲4.575.686.992026-02-27
TOP↑